Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Research Article
KEYWORDS Abstract Background: The study was designed to assess the ability of dexmedetomidine in differ-
Dexmedetomidine; ent regimens to produce controlled hypotensive anesthesia during functional endoscopic sinus sur-
Hypotensive anesthesia; gery in adults and the need to add an additional hypotensive agent in the form of nitroglycerin to
Alpha adrenergic agonists; achieve the target MAP.
Nitroglycerin Methods: In this blinded randomized controlled trail, 45 Patients, aged from 18 to 50 years, ASA
physical status I and II, underwent endoscopic sinus surgery were enrolled in the study. Before
induction of GA, all patients received bolus dexmedetomidine 1 l/kg iv more than 10 min. After
induction, Patients were randomly allocated into three groups, group Dex-0.4, in which patients
received dexmedetomidine infusion as 0.4 lg/kg/h, group Dex-0.8, in which patients received dex-
medetomidine infusion as 0.8 lg/kg/h and group Dex-P, in which patients received saline infusion.
The target MAP was 55–65 mmHg, if not achieved by the infused study drug, nitroglycerin infusion
was added in a titrating manner started with 0.1 lg/kg/min and increased gradually till the target
MAP is reached. The surgical field quality was assessed by using Fromme et al. bleeding score.
Results: The intraoperative MAP in group Dex-P and group Dex-0.8 was maintained within target
range at all time intervals. In group Dex-0.4, the MAP showed fluctuation to fall below and
increased above the target range at different time intervals. Unlike the other two groups, no
nitroglycerin infusion was needed in group Dex-0.8. Fromme et al. bleeding score showed the lowest
values in Dex-0.8 group and the highest values in group Dex-0.4. The differences between the three
groups were statistically significant with (P < 0.05).
1110-1849 ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.
Open access under CC BY-NC-ND license. http://dx.doi.org/10.1016/j.egja.2014.04.001
340 N.I. Abel Rahman et al.
the infused drug using 6 points scale by Fromm et al. scale [13] 3. Statistical analysis
adapted by Boezaart et al. [15]: 0 = no bleeding, 1 = slight
bleeding so blood evacuation not necessary, 2: slight bleeding We assumed a clinically significant difference of 50% reduc-
so sometimes blood has to be evacuated, 3 = low bleeding so tion in the requirements of additional hypotensive agent nitro-
blood has to be often evacuated and operative field is visible glycerine to achieve the target MAP with a power of 80% and
for some seconds after evacuation, 4 = average bleeding so (a = 0.05, one-tailed), and the sample size calculated was 36
blood has to be often evacuated, and operative field is visible patients (12/group) which will be increased to 45 patients
only right after evacuation and 5 = high bleeding so constant (15/group) for possible dropouts. Microsoft Excel 2010 and
blood evacuation is needed, sometimes bleeding exceeds evac- Statistical Package of Social Science software program, version
uation and surgery is hardly possible. The 1st assessment was 21 (SPSS) were used for all statistical comparisons (Chicago,
30 min after the beginning of surgery and then every 30 min till IL, USA). Continuous quantitative normally distributed data
the end of surgery. expressed as means and standard deviations (SD). Qualitative
All through the intraoperative period, mean arterial blood nominal data e.g. incidence of complications expressed as per-
pressure (MAP), heart rate (HR), were recorded before start- centage. Fisher’s exact test was used as appropriate to compare
ing the bolus infusion of dexmedetomidine (baseline), one qualitative data between the study groups. All other group
minute after termination of the bolus dexmedetomidine, one comparisons were made using analysis of variant (ANOVA)
minute after induction of GA, one minute after endotracheal test and Kruskal–Wallis ANOVA was used to compare Ram-
intubation and then every 10 min throughout the surgery till say sedation score and Fromme et al. field rating scale for
patient recovery and one minute before transfer to the post- bleeding between the three groups. P values of less than 0.05
anesthesia care unit (PACU). The total amount of nitroglyc- were considered statistically significant.
erine consumed throughout the procedure was recorded for
each patient as mg/patient. With termination of surgery, iso-
4. Results
flurane was discontinued, the oropharyngeal pack was
removed and the oropharynx was suctioned under direct
vision using the rigid laryngoscope. The residual atracurium Forty-five adult patients, met our inclusion criteria, were
was reversed with neostigmine 0.05 l/kg iv and atropine enrolled in the study and randomly allocated into 3 groups,
0.02 mg/kg iv when the TOF count is 2/4, trachea was extu- Dex-P (placebo), Dex-0.4 and Dex-0.8. All patients showed
bated once the patients showed eye opening and purposeful no significant differences regarding age, gender, weight, ASA
movement and then patients were transferred to PACU where classification, duration of surgery, duration of anesthesia and
BP, SpO2 and ECG were monitored. O2 supplementation was recovery characteristics including extubation time and time
provided via face mask. Sedation was assessed using Ramsay of interaction (Table 1).
sedation score (Appendix-1) on arrival to PACU, and then The Fromme et al. bleeding score showed the lowest values
every 30 min for 2 h. Complications such as desaturation in Dex-0.8 group and the highest values in group Dex-0.4. The
due to bronchospasm, laryngospasm, bleeding from surgical differences between the three groups were statistically signifi-
site or vomiting were recorded and managed. Recovery char- cant with (P < 0.05) at all assessment time points except at
acteristics were measured using Modified Aldrete’s Score time 60 min, and there was no statistically significant differ-
(MAS) on arrival to the PACU and every 30 min. Patients ence between group Dex-P and Dex-0.4 (Table 2).
were discharged from the PACU after achieving a modified Among the three groups, the MAP showed no significant dif-
Aldrete’s score of P9. The duration of surgery (the time from ferences between the baseline values and values measured one
start of surgical intervention till its end), the extubation time minute after bolus dose, after induction of GA and after endotra-
(the time from discontinuation of isoflurane till removal of cheal intubation. The intraoperative MAP values in both group
the endotracheal tube), the duration of anesthesia (time span Dex-P and group Dex-0.8 were kept almost constant within target
from induction of general anesthesia till the extubation) and range of our study all through the time interval, while the intraop-
time for interaction (the time from discontinuation of isoflu- erative MAP within the group Dex-0.4 showed fluctuation to fall
rane till verbal contact or response to commands) were below the target range at some time intervals (T20, 40, 60, 80) and
recorded. above the target range at other time intervals (T50,90) (Fig. 1).
Table 1 Patients characteristics, duration of surgery, duration of anesthesia, extubation time and time of interaction in the three
studied groups.
Dex-P (n-15) Dex-0.4 (n-15) Dex-0.8 (n-15)
Age (years) 39 ± 7 33 ± 9 42 ± 3
Gender (male/female) (9/6) (7/8) (5/10)
Weight (kg) 70 ± 9 68 ± 6 56 ± 11
ASA (I/II) (11/4) (13/2) (10/5)
Duration of surgery (min) 118 ± 21 129 ± 18 112 ± 23
Duration of anesthesia (min) 135 ± 19 141 ± 20 148 ± 17
Extubation time (min) 15 ± 4 18 ± 5 21 ± 3
Time of interaction (min) 32 ± 8 35 ± 8 40 ± 5
Data expressed as mean ± (SD). *means P value <0.05.
342 N.I. Abel Rahman et al.
The baseline HR showed no significant difference between compared to Dex-P at all time intervals. Ramsay score was
the three groups. One minute after the bolus dose of dexmede- higher in group Dex-0.8 when compared with group Dex-0.4
tomidine, the HR significantly decreased, about 25% from the at all-time intervals (P < 0.05) (Fig. 3).
base line values in the three groups (P < 0.05). HR rate did No significant difference between the three groups regard-
not significantly change after induction of GA in the three ing the amount of atracurium besylate consumption, Modified
groups. One minute after tracheal intubation, HR increased in Aldrete Score and adverse events as vomiting, laryngeal spasm
the three groups but this increase was not significant and did or bronchospasm.
not reach the baseline values. In group Dex-0.8, the HR was sig-
nificantly lower than that in Dex-0.4 and Dex-P from T20 till
T120 (P < 0.05). HR showed no significant difference between 5. Discussion
group Dex-0.4 and group Dex-P except at T30,80,130 the HR
was significantly higher in group Dex-0.4 (P < 0.05) (Fig. 2). In our study, applied on functional endoscopic sinus surgery
The number of patients experienced hypotension with in adult, dexmedetomidine as bolus dose 1 lg/kg iv followed
MAP < 55 mmHg and the number of ephedrine doses (one by iv infusion of 0.8 lg/kg/h significantly decreased the
dose = 6 mg iv) required were significantly higher in group MAP pressure to the target level without the need of an
Dex-0.4 when compared to either Dex-P or Dex-0.8. The num- additional hypotensive agent nitroglycerin iv infusion and
ber of patients experienced bradycardia with HR < 50 beat/ it provided the best surgical field quality by Fromme
min and the number of atropine doses were comparable et al. rating score. And also dexmedetomidine as only bolus
between the 3 groups (Table 3). 1 lg/kg iv followed by nitroglycerine infusion decreased the
The target MAP was reached in all patients in group Dex- MAP to the target level without significant increase in the
0.8 without need of using nitroglycerine infusion, unlike HR and the surgical field conditions were satisfactory for
patients in group Dex-0.4 and Dex-p in which all patients surgeons. But dexmedetomidine as bolus dose 1 lg/kg iv fol-
needed nitroglycerine infusion to reach the target MAP. The lowed by iv infusion of 0.4 lg/kg/h was not sufficient to
requirements of nitroglycerine in group Dex-P were lower the MAP to the target level and the use of an addi-
(10.8 ± 3.2 mg/patient) which was significantly higher than tional hypotensive agent nitroglycerin iv infusion was associ-
group Dex-0.4 (4.7 + 1.3 mg/patient) (P < 0.05) (Table 3). ated with fluctuation of the MAP above and below the
Ramsay sedation scores measured in the PACU were signif- target values and the surgical field conditions were not sat-
icantly higher in both group Dex-0.8 and Dex 0.4 when isfactory for surgeons.
Efficacy of different dexmedetomidine regimens 343
† †
†
Figure 2 Intraoperative HR in the three groups: *P < 0.05 in dex-0.8 vs dex0.4 & dex-p, P < 0.05 in dex-p vs dex-0.4.
Figure 3 Ramsay sedation score: *P < 0.05 among the three groups.
344 N.I. Abel Rahman et al.
In our study, we chose a target MAP 55–65 mmHg to pro- medetomidine. Nitroglycerine especially in small dose causes
vide the best surgical conditions without the risk of tissue vasodilatation more on the capacitance venous vessels rather
hypo-perfusion depending on a study conducted by Yoshika- than that on the arteriolar vessels, and with the patient’s
wa et al. [14] concluded that hypotensive anesthesia induced supine position with head up 30 commonly used in FESS sur-
by using sodium nitroprusside or nitroglycerine in mandibular geries, polling of the blood into the capacitance vessels helps in
osteotomy to achieve MAP 60–70 mmHg is safe and associ- developing some degree of postural hypotension [21].
ated with no significant increase in pyruvate, lactate or glucose Referring to previous studies used dexmedetomidine to
levels, and another study conducted by Boezaart et al. [1] dem- induce hypotensive anesthesia, In a placebo controlled clinical
onstrated that the best surgical conditions for FESS obtained trial conducted by Ayoglu et al. [11], to assess to what extent
when the MAP ranged between 50 and 54 mmHg. Also, it is the dexmedetomidine at infusion rate of 0.7 lg/kg/h is effective
reported that the best operative field quality in FESS surgeries in reducing the bleeding from the surgical field during septo-
by using Fromme et al. rating scale is 2–3 points [1,15] plasty and tympanoplasty. Despite authors could not achieve
Unfortunately, no sufficient clinical trials studied the effec- their target MAP (30% reduction from the preoperative value)
tiveness of combining a2-agonist (either clonidine or dexmede- at this infusion rate, but dexmedetomidine succeeded to pro-
tomidine) infusion and direct vasodilator nitroglycerine vide a good surgical field.
infusing in producing controlled hypotensive anesthesia. In a Another clinical trial conducted by Aboushanab et al. [12],
study conducted by Sahin et al., comparing dexmedetomidine comparing the hypotensive effect of dexmedetomidine with
and alfentanil in producing hypotensive anesthesia during mid- that of magnesium sulfate during middle ear surgeries, they
dle ear surgery, they had to use nitroglycerine iv infusion demonstrated that dexmedetomidine infusion at rate of 0.4–
started from rate of 0.5 lg/kg/min in 3 out of 20 patients in dex- 0.8 lg/kg/h succeeded to reduce the MAP to their target 60–
medetomidine group to achieve the target MAP 50–65 mmHg, 70 mmHg, despite this MAP is higher than that used in our
however, they did not comment on the effect of such combina- study but the authors demonstrated the ability of dexmede-
tion [24]. The synergistic effect of combining infusion of dex- tomidine to provide very good surgical field.
medetomidine and nitroglycerin that found in our study Another placebo controlled trial conducted by Nasreen
group Dex-0.4 may be explained by the different mechanisms et al. [22], using low dose dexmedetomidine (0.4 lg/kg/h) in
of action of both agents, the effect of premedication with a2- addition to titrated halothane vol% in order to reduce MAP
agonist on baroreflex response in anesthetized patients and 30% from the preoperative values during middle ear surgeries,
the patient positioning required during FESS surgery. they observed significant reduction in halothane requirement
Dexmedetomidine stimulates a2-receptors located in pre- in dexmedetomidine group with better surgical field compared
synaptic nerve terminal enhances the negative feedback loop to placebo group.
that inhibits the release of noradrenaline from the nerve ter- Another observation in our study is the ability of the pre-
minal [16], while stimulation of the a2-receptor located in induction bolus dose 1 lg/kg of dexmedetomidine to attenuate
locus ceruleus of brainstem is responsible for the sedative the hemodynamic response to direct laryngoscopy and endo-
and hypnotic effect of dexmedetomidine and its ability to tracheal intubation as no significant increase in HR or MAP
reduce the central sympathetic output [16,17] both cause in the 3 groups 1 min after inserting the endotracheal tube,
vasodilatation and decrease in blood pressure. It is should the same observation was found in a study conducted by
be noted that dexmedetomidine stimulates the postsynaptic Bajwa et al. [23] whom reported the ability of dexmedetomi-
a2-receptors in vascular smooth muscle and this produces dine 1 lg/kg iv infusion more than 20 min given as premedica-
vasoconstriction [16] which is opposed by endothelial nitric tion to attenuate the pressor response to endotracheal
oxide synthesis [18]. intubation, surgery and extubation.
Nitroglycerin has a non-specific, direct vasodilator effect on In our study, there was no significant difference in the
the venous capacitance vessels and incidentally on the arteries; extubation time or time of interaction between the three
it has a short half-life, it increases venous blood volume and groups, a finding that can be explained by nature of dex-
reduces venous return, so cardiac output is proportionally medetomidine as a sedative not hypnotic agent so patients
reduced [2] Nitroglycerin mediates its action via its metabolite receiving it will be sedated but easily arousable. Same obser-
nitric oxide which activates guanylyl cyclase lead to increase vation found by Nasreen et al. [22] who reported significant
cGMP, this will reduce the intracellular calcium and relax reduction in the awakening time in patients receiving
the vascular smooth muscle [16]. dexmedetomidine when compared to placebo group. But in
The baroreflex response is one of the body’s homeostatic disagreement with our finding, Aboushanab et al. [12]
mechanisms for maintaining the blood pressure; it is mediated reported longer recovery time in patients receiving dexmede-
through the baroreceptors located in the aortic arch and carotid tomidine when compared to those received magnesium sulfate
sinuses. The baroreflex response to increased blood pressure is as hypotensive techniques during middle ear surgery. Also
mainly vagal (decreases the heart rate and blood pressure) while Richa et al [4] reported prolonged extubation time in patients
the baroreflex response to decreased blood pressure is mainly receiving dexmedetomidine when compared to those received
sympathetic (increases the heart rate and blood pressure) [19]. remifentanil for controlled hypotensive anesthesia during
In a study conducted by Watanabe et al. [20], they demon- tympanoplasty.
strated that in patients premedicated with a2-agonist clonidine Our study limitations include the following: first inability to
and underwent general anesthesia, the baroreflex response to assess the depth of anesthesia and the effect of dexmedetomi-
increased blood pressure is unchanged but become attenuated dine on isoflurane requirements due to unavailability of BIS
in response to decreased blood pressure. monitoring. Second we did not use a score for assessing the
The patient’s position during FESS surgeries may play a postoperative pain, however the FESS is usually followed
role in explain the synergistic action of nitroglycerine and dex- headache sensation rather than pain and it was managed
Efficacy of different dexmedetomidine regimens 345
successfully by iv paracetamol preparation on patients [7] Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs
complained. 2000;59:263–8.
[8] Gurbet A, Basagan-Mogol E, Turker G, Ugun F, Kaya FN,
Ozcan B. Intraoperative infusion of dexmedetomidine reduces
6. Conclusion
perioperative analgesic requirements. Can J Anaesth
2006;53(7):646–52.
From our clinical trial applied on functional endoscopic sinus [9] Ohtani N, Yasui Y, Watanabe D, Kitamura M, Shoji K, Masaki
surgery in adult ASA I,II we concluded that, dexmedetomidine E. Perioperative infusion of dexmedetomidine at a high dose
regimen as pre-induction bolus dose 1 lg/kg iv followed by reduces postoperative analgesic requirements: a randomized
post-induction continuo iv infusion 0.8 lg/kg/h significantly control trial. J Anesth 2011;25(6):872–8.
decreased the mean arterial blood pressure to the target level [10] Richa F, Yazigi A, Sleilaty G, Yazbeck P. Comparison between
dexmedetomidine and remifentanil for controlled hypotension
without the need of an additional hypotensive agent nitroglyc-
during tympanoplasty. Eur J Anaesthesiol 2008;25(5):
erin, and it provides the excellent surgical field quality when 369–74.
compared to other regimens. [11] Ayoglu H, Yapakci O, Ugur MB, Uzun L, Altunkaya H, Ozer
Dexmedetomidine used as only pre-induction bolus dose Y. Effectiveness of dexmedetomidine in reducing bleeding
1 lg/kg iv followed by post-induction nitroglycerine iv infu- during septoplasty and tympanoplasty operations. J Clin
sion decreased the mean arterial blood pressure to the target Anesth 2008;20(6):437–41.
level and avoid the reflex tachycardia and provide satisfactory [12] Aboushanab OH, El-Shaarawy AM, Omar AM, Abdelwahab
surgical field quality. HH. A comparative study between magnesium sulphate and
dexmedetomidine for deliberate hypotension during middle ear
surgery. Egypt J Anaesth 2011;27:227–32.
Conflict of interest
[13] Fromme GA, MacKeinzie RA, Gould ABJr, Lund BA, Offord
KP. Controlled hypotension for orthoganthic surgery. Anesth
No conflict of interest in this study. Analg 1986;65:683–6.
[14] Yashikawa F, Kohase H, Umino M, Fukayama H. Blood loss
and endocrine responses in hypotensive anaesthesia with sodium
nitroprusside and nitroglycerin for mandibular osteotomy. Int J
Appendix A. Ramsay sedation score Oral Maxillofac Surg 2009;38:1159–64.
[15] Jacobi KE, Bohm BE, Rickauer AJ, Jacobi C, Hemmerling TM.
Moderate controlled hypotension with sodium nitroprusside
does not improve surgical conditions or decrease blood loss in
Score Observation endoscopic sinus surgery. J Clin Anesth 2000;12:202–7.
1 Anxious, agitated or restless [16] Morgan GA, Mikhail MS, Murray MJ. Clinical anesthesiology.
2 Cooperative, oriented and tranquil 4th ed. Land Medical Books/McGraw-Hill, Medical publishing
3 Responsive to commands Division; 2006, chapter 13, p. 262.
4 Asleep, but with brisk response to light glabellar tap or loud [17] Carollo DS, Nossaman BD, Usha R. Dexmedetomidine: a
auditory stimulus review of clinical applications. Curr Opin Anaesthsiol
5 Asleep, sluggish response to glabellar tap or auditory 2008;21:457–61.
Stimulus [18] Snapir A, Talke P, Posti J, Huiku M, Kentala M, Scheinin M.
6 Asleep, no response Effects of nitric oxide synthase inhibition on dexmedetomidine
induced vasoconstriction in healthy human volunteers. Br J
Anaesth 2009;102:38–46.
[19] Dohi S, Tsuchida H, Mayumi T. Baroreflex control of heart rate
during cardiac sympathectomy by epidural anesthesia in lightly
References anesthetized humans. Anesth Analg 1983;4:109–23.
[20] Watanabe Y, Iida H, Tanabe K, Ohata H, Dohi S. Clonidine
[1] Boezaart AP, Merwe J, Coetzee A. Comparison of sodium premedication modifies response to adrenoceptor agonists and
nitroprusside and esmolol induced controlled hypotension for baroreflex sensitivity. Can J Anaesth 1998;45(11):1084–90.
functional endoscopic sinus surgery. Can J Anaesth 1995;42:373–6. [21] Cincikas D, Ivaskevicius J. Application of controlled arterial
[2] Degoute CS. Controlled hypotension: a guide to drug choice. hypotension in endoscopic rhinosurgery. MEDICINA
Drugs 2007;67:1053–76. 2003;39(9):852–9.
[3] Degoute CS, Ray MJ, Gueugniaud PY, Dubreuil C. [22] Nasreen F, Bano Sh, Khan RM, Hasan SA. Dexmedetomidine
Remifentanil induces consistent and sustained controlled used to provide hypotensive anesthesia during middle ear
hypotension in children during middle ear surgery. Can J surgery. Indian J Otolaryngol Head Neck Surg 2009;61(July–
Anaesth 2003;50:270–6. Septemper):205–7 (July–Septemper).
[4] Richa F, Yazigi A, Sleilaty G, Yazbeck P. Comparison between [23] Bajwa SJS, Kaur J, Singh A, Parmar SS, Singh G, Kulshrestha
dexmedetomidine and remifentanil for controlled hypotension A. Attenuation of pressor response and dose sparing of opioids
during tympanoplasty. Eur J Anaesthesiol 2008;25:369–74. and anaesthetics with pre-operative dexmedetomidine. Indian J
[5] Venn R, Bradshaw C, Spencer R, et al. Preliminary experience Anaesth 2012;56(2):123–8.
of dexmedetomidine, a novel agent for postoperative sedation in [24] Sahin F, Deren S, Erdogan G, Ornek D, Dikmen B.
the intensive care unit. Anaesthesia 1999;54:1136–42. Comparison of dexmedetomidine and alfentanil during middle
[6] Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline ear surgery. Int Adv Otol 2011;7(2):225–33.
receptor agonists: their pharmacology and therapeutic role.
Anaesthesia 1999;54:146–65.